ORBERA™ Intragastric Balloon System
What is ORBERA™?
- Comprehensive two-part program designed to provide effective, motivating results that you can see. With ORBERA™ patients on average lose 3.1 times the weight they would with diet and exercise alone.
- Starts with a soft balloon placed in your stomach for six months to reinforce proper portion control.
- The ORBERA balloon takes up space in your stomach helping you to eat smaller meals.
- Balloon is temporary and placed in your stomach for six months without surgery or any incisions.
- Patients will receive coaching from a team of experts, which may include a dietician, psychologist, and exercise physiologist.
- Coaching continues after balloon is removed at six months for a total of 12 months.
The Procedure: Placement and removal
- Non-surgical procedure done under a mild sedative, the thin and deflated ORBERA™ balloon is placed into the stomach. It is then filled with saline until it’s about the size of a grapefruit. The procedure typically takes about 20-30 minutes so you can go home the very same day.
- At six months, the balloon is removed in the same way it was placed. Through a non-surgical procedure done under a mild sedative, it is deflated first then removed.
What to Expect
- The weight loss is rapid with the majority of weight loss typically occurring in the first three months of treatment.
- On average patients lost 3.1 times the weight loss of diet and exercise alone.
- The adjustments to your eating habits and your continued efforts to stay active will greatly influence your results.
To qualify for ORBERA™, you should:
- Be an adult
- Body Mass Index (BMI) of 30 to 40
- Be willing to participate in a medically supervised program
- After six months with the ORBERA™ two-part program, people lost an average 3.1 times the weight patients lost with diet & exercise alone.
- Proven to keep the weight off even after the balloon is removed.
- A more than 20 year history of helping thousands of people lose weight.
- More than 220,000 ORBERA™ balloons have been distributed worldwide in over 80 countries.
- With the FDA approval of ORBERA™, patients now have a safe and effective treatment option.
Meet Our Orbera Doctor
Dr. Scharf is Assistant Professor of Surgery, Minimally Invasive Surgery and Bariatric Sugery at Loma Linda University School of Medicine. He received his medical degree from Lake Erie College of Osteopathic Medicine and continued on with his Residency in General Surgery at Michigan State University and Loma Linda University Medical Center. Dr. Scharf completed a Fellowship in Minimally Invasive Surgery and Bariatric Surgery at Stanford University. Research specialties include: Metabolic, Bariatric and Minimally Invasive Surgery.
Directions For Use (DFU). ORBERA™ Intragastric Balloon System (ORBERA™). Austin, TX: Apollo Endosurgery, Inc.